Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 355

1.

Presence of antibodies against cyclic citrullinated peptides in patients with 'rhupus': a cross-sectional study.

Amezcua-Guerra LM, Springall R, Marquez-Velasco R, Gómez-García L, Vargas A, Bojalil R.

Arthritis Res Ther. 2006;8(5):R144.

2.

Anti-citrullinated peptide antibodies in lupus patients with or without deforming arthropathy.

Damián-Abrego GN, Cabiedes J, Cabral AR.

Lupus. 2008 Apr;17(4):300-4. doi: 10.1177/0961203307087613.

PMID:
18413411
3.

What can we learn from the presence of anti-cyclic citrullinated peptide antibodies in systemic lupus erythematosus?

Zhao Y, Li J, Li XX, Li C, Li L, Li ZG.

Joint Bone Spine. 2009 Oct;76(5):501-7. doi: 10.1016/j.jbspin.2008.11.007. Epub 2009 Mar 16.

PMID:
19289297
4.

Determination of anti-cyclic citrullinated peptide antibodies in the sera of patients with juvenile idiopathic arthritis.

Low JM, Chauhan AK, Kietz DA, Daud U, Pepmueller PH, Moore TL.

J Rheumatol. 2004 Sep;31(9):1829-33.

PMID:
15338508
5.

The detecting and clinical value of anti-cyclic citrullinated peptide antibodies in patients with systemic lupus erythematosus.

Qing YF, Zhang QB, Zhou JG, Yuan GH, Wei J, Xing Y, Liu JP, Jiang L, Chen JP.

Lupus. 2009 Jul;18(8):713-7. doi: 10.1177/0961203309102817.

PMID:
19502267
6.

Anti-agalactosyl IgG antibodies in Thai patients with rheumatoid arthritis, systemic lupus erythematosus, and systemic sclerosis.

Louthrenoo W, Kasitanon N, Wichainun R, Wangkaew S, Sukitawut W, Kuwata S, Takeuchi F.

Clin Rheumatol. 2010 Mar;29(3):241-6. doi: 10.1007/s10067-009-1284-y. Epub 2009 Nov 29.

PMID:
20091076
7.

Associations of erosive arthritis with anti-cyclic citrullinated peptide antibodies and MHC Class II alleles in systemic lupus erythematosus.

Chan MT, Owen P, Dunphy J, Cox B, Carmichael C, Korendowych E, McHugh NJ.

J Rheumatol. 2008 Jan;35(1):77-83. Epub 2007 Dec 15.

PMID:
18085741
8.

[The role of anti-cyclic citrullinated peptide (anti-CCP) antibodies in serologic diagnosis and evaluation of disease activity in rheumatoid arthritis].

Aridoğan BC, Kaya S, Savaş S, Cetin ES, Akkuş S, Demirci M.

Mikrobiyol Bul. 2008 Oct;42(4):669-74. Turkish.

PMID:
19149089
9.

The significance of rheumatoid factor and anti-cyclic citrullinated peptide antibodies in systemic lupus erythematosus.

Popescu C, Zofotă S, Bojincă V, Ionescu R.

Rom J Intern Med. 2013 Jul-Dec;51(3-4):179-87.

PMID:
24620631
10.

Alpha-actinin-binding antibodies in relation to systemic lupus erythematosus and lupus nephritis.

Becker-Merok A, Kalaaji M, Haugbro K, Nikolaisen C, Nilsen K, Rekvig OP, Nossent JC.

Arthritis Res Ther. 2006;8(6):R162.

11.

The HLA-DRB1 shared epitope is not associated with antibodies against cyclic citrullinated peptide in Chinese patients with rheumatoid arthritis.

Xue Y, Zhang J, Chen YM, Guan M, Zheng SG, Zou HJ.

Scand J Rheumatol. 2008 May-Jun;37(3):183-7. doi: 10.1080/03009740701874444.

PMID:
18465452
12.

Anti-cyclic citrullinated peptide antibodies distinguish hepatitis B virus (HBV)-associated arthropathy from concomitant rheumatoid arthritis in patients with chronic HBV infection.

Lim MK, Sheen DH, Lee YJ, Mun YR, Park M, Shim SC.

J Rheumatol. 2009 Apr;36(4):712-6. doi: 10.3899/jrheum.080653. Epub 2009 Mar 13.

PMID:
19286846
13.

Multiple antibody reactivities to citrullinated antigens in sera from patients with rheumatoid arthritis: association with HLA-DRB1 alleles.

Snir O, Widhe M, von Spee C, Lindberg J, Padyukov L, Lundberg K, Engström A, Venables PJ, Lundeberg J, Holmdahl R, Klareskog L, Malmström V.

Ann Rheum Dis. 2009 May;68(5):736-43. doi: 10.1136/ard.2008.091355. Epub 2008 Jul 17.

PMID:
18635594
14.

'Rhupus' syndrome.

Panush RS, Edwards NL, Longley S, Webster E.

Arch Intern Med. 1988 Jul;148(7):1633-6.

PMID:
3382309
15.

Antibodies against cyclic citrullinated peptides in patients affected by rheumatoid arthritis before and after infliximab treatment.

Caramaschi P, Biasi D, Tonolli E, Pieropan S, Martinelli N, Carletto A, Volpe A, Bambara LM.

Rheumatol Int. 2005 Nov;26(1):58-62. Epub 2005 Feb 23.

PMID:
15726373
16.

Prospective cohort study of effects of infliximab on rheumatoid factor, anti-cyclic citrullinated peptide antibodies and antinuclear antibodies in patients with long-standing rheumatoid arthritis.

Bruns A, Nicaise-Roland P, Hayem G, Palazzo E, Dieudé P, Grootenboer-Mignot S, Chollet-Martin S, Meyer O.

Joint Bone Spine. 2009 May;76(3):248-53. doi: 10.1016/j.jbspin.2008.09.010. Epub 2009 Feb 8.

PMID:
19208451
18.

Usefulness of anti -CCP antibodies in rheumatic diseases in Indian patients.

Gupta R, Thabah MM, Aneja R, Kumar A, Varghese T, Chandrasenan PJ.

Indian J Med Sci. 2009 Mar;63(3):92-100.

PMID:
19359776
19.

Determination of the subset of Sjogren's syndrome with articular manifestations by anticyclic citrullinated peptide antibodies.

Iwamoto N, Kawakami A, Tamai M, Fujikawa K, Arima K, Aramaki T, Kawashiri S, Ichinose K, Kamachi M, Nakamura H, Origuchi T, Ida H, Eguchi K.

J Rheumatol. 2009 Jan;36(1):113-5. doi: 10.3899/jrheum.080193.

PMID:
19132785
20.

Profile of autoantibodies in Jaccoud's arthropathy.

Galvão V, Atta AM, Sousa Atta ML, Motta M, Dourado S, Grimaldi L, Oliveira e Silva N, Silva de Oliveira I, Santiago MB.

Joint Bone Spine. 2009 Jul;76(4):356-60. doi: 10.1016/j.jbspin.2008.11.003. Epub 2009 Mar 10.

PMID:
19278880

Supplemental Content

Support Center